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Abstract
Mutations in collagen II are associated with spondyloepiphyseal dysplasia, a group of heritable diseases
whose common features include aberrations of skeletal growth. The mechanisms through which
mutations in collagen II affect the cartilaginous tissues are complex and include both intracellular and
extracellular processes. One of those mechanisms involves cellular stress caused by excessive
accumulation of misfolded collagen II mutants. We investigated whether stabilizing the structure of
thermolabile R789C and R992C collagen II mutants would improve their secretion from cells, thereby
reducing cellular stress and apoptosis. Employing glycerol and trimethylamine N-oxide (TMAO),
chemicals that increase the thermostability of collagen triple helices, we demonstrated that those
compounds function as chaperones and stabilize the R789C and R992C mutants, accelerate their
secretion, and improve cell survival. Our study provides a scientific basis for considering misfolded triple
helices of collagen mutants a target for reducing the deleterious effects caused by their excessive
intracellular accumulation.
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Introduction
Collagen II is a component of heterotypic fibrils which form scaffolds of mature cartilaginous tissues
and provide a template that guides the development of skeletal tissues [1]. Processes leading from the
biosynthesis of pro-α1(II) chains in cells to the formation of collagen fibrils in the extracellular space are
complex and include: (i) posttranslational modifications of nascent pro-α1(II) chains, (ii) their folding
into triple-helical procollagen molecules and secretion from cells, and (iii) self-assembly of collagen
molecules into fibrils [2].
Fundamental for the mechanical and biological functions of collagen II is its stable triple-helical
conformation. Such a conformation is achieved by the folding of individual pro-α1(II) chains whose main
collagenous domain consists of uninterrupted repetitions of the G-X-Y motif in which the “X” and the
“Y” positions are frequently occupied by proline and hydroxyproline residues, respectively [2]. The
accurate amino acid sequence of collagen II is critical for the correct functions of this protein at the tissue
level and mutations in COL2A1 (OMIM#120140) are associated with a broad spectrum of
chondrodysplasia phenotypes, generally described as spondyloepiphyseal dysplasia (SED), the main
feature of which is abnormal skeletal development [3]
One of the pathological consequences of mutations in collagenous proteins is a loss-of-function
effect due to the reduced incorporation of mutants into the extracellular matrix (ECM). It has been
suggested that the fundamental cause for the reduced amount of collagen molecules containing mutant α
chains is excessive intracellular accumulation and subsequent degradation in a process described as
"procollagen suicide" [4].
Due to the possibility of excessive intracellular retention, some diseases that involve collagen
mutants are categorized as storage diseases, a group that also includes diseases caused by the excessive
accumulation of non-collagenous proteins, lipids, glycoproteins, and other macromolecules [5]. In our
studies published elsewhere we demonstrated that the R789C and R992C substitutions in collagen II
cause misfolding of mutant molecules, decrease their thermostabilities, promote excessive intracellular
retention and aggregation, and increase apoptosis [6; 7; 8]. Thus, in addition to the loss-of-function effect,
certain mutations in collagen II may also cause a gain-of-toxicity effect.
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Here, we studied the feasibility of reducing cellular stress associated with the R789C and R992C
substitutions by stabilizing the mutant molecules and decreasing their intracellular accumulation.
Employing glycerol and trimethylamine N-oxide (TMAO), chemicals that stabilize the collagen triple
helix, we demonstrated that these compounds increase the thermostability of the R789C and R992C
mutants, decrease their intracellular retention, and improve cell survival [9; 10; 11],. Our study provides
bases for considering triple helices of thermolabile collagen mutants a new target to reduce the deleterious
effects caused by their atypical retention.

Materials and Methods
Mutation nomenclature -- The amino acid substitutions are named according to the literature, with
amino acid residues numbered from the first glycine of the collagen II triple helix.

Procollagen II mutants -- Procollagen II mutants employed in this study are associated with SED
[12; 13]. To facilitate various biochemical and microscopic assays, wild type (WT) and mutant
procollagen II variants were engineered as chimeras fused with green fluorescent protein (Pro-GFP), as
described [6; 8].

Cells expressing collagen II mutants -- For the production of Pro-GFP variants in quantities
sufficient for assays of their thermostability, these proteins were expressed in HT-1080 cells (ATCC;
CCL-121), as described [6; 8; 14]. For analyses of cellular responses to the presence of procollagen II
mutants, the chondrocytic cell line SW-1353 (ATCC; HTB-94) was employed, as described [6; 7; 8].
Both cell lines were cultured in Dulbecco's Modified Eagle Medium supplemented with 10% fetal bovine
serum and 40 µg/ml of L-ascorbic acid phosphate magnesium salt (Wako Chemicals, Inc.), as described
[8; 14].

Cell culture in the presence of glycerol and TMAO -- Glycerol and TMAO, compounds with
chemical chaperone characteristics, were employed to determine the effects of their collagen-stabilizing
activities on the structure of the R789C and R992C mutants, and the faith of cells harboring them. For
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analyses of cell survival, we followed the experimental design described by Hintze et al [7]. In brief, SW1353 cells were cultured for 12 days post-confluence, and then cell culture media were supplemented with
glycerol added to a final concentration of 0.1 M or 0.5 M, or TMAO added at 30 mM or 0.1 M.
Subsequently, cell culture was continued for five additional days. After the five-day treatment, cell
culture media and cell lysates were collected for further assays. For thermostability analyses, collagen II
variants were isolated from HT-1080 cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO, as
described [14].
Working concentrations of selected compounds used in this study were determined in pilot
experiments. In these experiments cells were cultured in increasing concentrations of glycerol or TMAO.
During culture, cells were monitored for proliferation, changes in morphology, and production of
procollagen II, as described [6; 8]. The highest concentrations that did not have any apparent negative
effects on cultured cells were applied in the presented studies.

Cleaved poly-(ADP-ribose) polymerase (cPARP) and TdT-mediated dUTP Nick-End Labeling
(TUNEL) assays -- Glycerol and TMAO-treated cells were analyzed for apoptotic markers, as described
[7]. In these assays cPARP was detected in cell lysates by Western blot with primary rabbit anti-cPARP
antibodies (Cell Signaling Technology, Inc.) and secondary anti-rabbit IgG conjugated to horseradish
peroxidase (HRP; Sigma-Aldrich). The same nitrocellulose membranes were also probed for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The relative amount of cPARP in the analyzed
samples was determined by measuring the ratios of the pixel intensities of the cPARP-positive bands and
GAPDH-positive bands. In any given group of cells, i.e. expressing GFP-tagged WT, R789C or R992C
collagen II, the cPARP/GAPDH ratio derived from non-treated cells was considered 100%. Statistical
significances of differences between the means calculated for the relative contents of cPARP in cells
cultured in the presence vs. the absence of tested compounds were evaluated by the Student’s t test
(GraphPad Software, Inc.).
In another set of experiments the presence of fragmented DNA was analyzed by TUNEL assays that
utilize tetramethylrodamine (TMR) as a red fluorophore (Roche). Subsequently the apoptotic index,
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defined as the percentage of TUNEL-positive nuclei out of the total number of DAPI-positive nuclei, was
calculated for each analyzed group, as described [6; 7].

Thermostability assays of collagen II variants -- Two experimental approaches were designed; (i) in
the first approach we analyzed the thermostabilities of purified collagen II mutants produced by HT-1080
cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO, and (ii) in the second approach these
compounds were added to purified collagen II variants produced by cells cultured in the absence of these
compounds. The thermostabilities were measured by brief protease digestion, as described [6; 15]. Based
on collagen II-melting curves, we determined the temperatures at which the triple helical structure of
analyzed collagens was preserved in 75% (Tm75), 50% (Tm50), and 25% (Tm25) of maximum.

Intracellular Pro-GFP variants produced in the presence of glycerol and TMAO -- We analyzed
whether glycerol and TMAO-mediated stabilization of collagen molecules could also influence their
intracellular accumulation. In brief, glycerol or TMAO-treated cells were lysed, and then Pro-GFP
variants were detected by Western blot assays with an anti-GFP antibody, as described [6; 8]. The relative
content of GFP-positive bands was assayed by densitometry. The results of measurements were
normalized to GAPDH and plotted as a percent of the non-treated control (expressed as 100%).

We also studied the effects of glycerol and TMAO on the accumulation of collagen
molecules misfolded due to inhibition of critical hydroxylation of proline residues by 2,2'
dipyridyl (Sigma-Aldrich) [16]. The intracellular content of Pro-GFP variants produced in the
presence of 2,2' dipyridyl was assayed as described above.

Results
Apoptotic markers in cells harboring the R789C and R992C mutants cultured in the presence
of glycerol and TMAO -- Cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO had a
statistically significant decrease in the relative amount of cPARP, indicating an increase of cell survival
(Fig. 1 and Supplementary Fig. S1). In the same experimental conditions, the overall amounts of Pro-GFP
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produced by cells did not change (Fig. 1). The lower concentrations of these compounds used in the pilot
studies did not have significant effects on relative amounts of cPARP (data not shown).
TUNEL analyses (Supplementary Fig. S2) of cells cultured in the presence of 0.5 M glycerol or 0.1
M TMAO support the results of cPARP assays. Specifically, we determined that in comparison to the
non-treated cells harboring the WT, R789C or the R992C mutants, the apoptotic indexes for cells cultured
in the presence of 0.5 M glycerol decreased from 0.89% (±0.15 SEM), 3.45% (±0.73 SEM), and 0.96%
(±0.12 SEM), to 0.82% (±0.14 SEM), 2.34% (±0.3 SEM), and 0.5% (±0.11 SEM), respectively. A similar
trend was observed in an analogous experiment where cells were treated with 0.1 M TMAO. Specifically,
we determined that in comparison to the non-treated cells harboring the WT, R789C or the R992C
mutants (see above) the apoptotic indexes for cells cultured in the presence of 0.1 M TMAO decreased to
0.56% (±0.14 SEM), 2.24% (±0.22 SEM), and 0.67% (±0.08 SEM), respectively.

Thermostabilities of the R789C and R992C mutants produced by cells cultured in the presence of
glycerol or TMAO -- In comparison to the non-treated controls, the thermostabilities of the WT collagen
II and the analyzed mutants produced by cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO
have increased (Fig. 2A, Supplementary Fig. 3S, and Tab. 1). Based on this observation, however, it has
not been clear whether the thermostabilizing effect depended on intracellular interactions of glycerol and
TMAO with newly synthesized pro-α1(II) chains or whether these compounds were able exert a
stabilizing effect extracellularly. Thus, in another set of experiments, we first prepared collagen II
variants isolated from cells cultured in the absence of chaperones. Next, purified collagens were exposed
to these compounds for 24-h at 4°C, and then thermostability measurements were performed. Because the
thermostabilities of analyzed mutants have increased, these assays suggest that intracellular interaction
between the chemical chaperones and procollagen is not a defining factor in stabilizing the collagen II
variants (Fig. 2B, Supplementary Fig. 3S, and Tab. 1). When comparing the thermostabilities of the
collagen variants purified from cultures of cells grown in the presence of chaperones to those isolated
from cells grown in chaperone-free media and treated with chaperones right before the stability assays, it
is apparent that the increase in thermostability was greater in the latter group. (Fig. 2 and Tab. 1).
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Note: As glycerol and TMAO do not change the enzymatic activities of trypsin and chymotrypsin, it
is important to emphasize that the observed increase of thermostabilities of collagen II variants was not a
result of the decrease of the enzymatic activities of employed proteases [17].
Intracellular accumulation of the R789C and R992C mutants -- We analyzed the intracellular
content of Pro-GFP variants in the presence of glycerol and TMAO. In comparison to the non-treated
controls, in cells treated with these compounds the relative amounts of the R789C and R992C variants
were reduced (Fig. 3 and Fig. 4). Of note was the observation that in cells expressing the R789C mutant,
partial degradation of this protein was observed.

As shown in Fig. 3 and Fig. 4 adding 2,2' dipyridyl into the cell culture increased accumulation of
Pro-GFP in all analyzed groups. Moreover, as evident by the presence of GFP-positive fragments,
increased intracellular accumulation was associated with degradation of all Pro-GFP variants. In addition,
in cells cultured in the presence of this compound, neither glycerol nor TMAO reduced the intracellular
accumulation of the Pro-GFP variants (Fig. 3 and Fig. 4).

Discussion
Employing a simple experimental system, we tested whether adverse consequences of intracellular
accumulation of the thermolabile R789C and R992C collagen II mutants could be partially reduced by
improving their thermostabilities. The strategy proposed here was to employ glycerol and TMAO,
compounds that at 1 M concentration increase the thermostability of collagen triple helices by 1°C and
5°C, respectively [9; 10].
We demonstrated that the presence of glycerol and TMAO was associated with reduction of the
relative amounts of cPARP in cells harboring the R789C and R992C mutants. At the same time, the
presence of these compounds did not affect the overall production of collagen II. In cells expressing WT
collagen II, the relative amount of background-level cPARP also decreased, but this change was relatively
small compared to that observed for cells harboring collagen II mutants. The decrease in the apoptotic
indexes for cells expressing the R789C and R992C variants in the presence of glycerol and TMAO further
corroborates the results of quantitative assays of cPARP. Changes in the relative amounts of apoptotic
markers in cells cultured in the presence of glycerol or TMAO correlated with the decrease of the
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intracellular pool of procollagen molecules, suggesting the increase of their secretion. Because the
efficient secretion of procollagens depends on the formation of thermostable triple-helical structures, the
decrease of intracellular accumulation of inherently thermolabile R789C and R992C procollagen II
mutants in the presence of glycerol and TMAO further indicate the chaperone-like collagen-stabilizing
effect of these compounds [6; 7; 16; 18; 19]. The collagen-stabilizing activity of selected chemical
chaperones, however, is probably limited to mutant molecules with localized structural aberrations. This
notion is based on the observation that collagen molecules whose structures are extensively misfolded due
to the inhibition of hydroxylation of proline residues by 2,2' dipyridyl are not stabilized by selected
chemical chaperones..
The decrease in the intracellular accumulation of studied mutants indicates that the stabilizing effects
of glycerol and TMAO were primarily a result of the intracellular influence of these compounds on the
structure of a collagen triple helix. In comparison to the stabilities of collagen II variants purified from
cell culture media of cells grown in the presence of glycerol or TMAO, the increase in the thermostability
was even greater in another experimental group in which these compounds were added to the purifiedcollagen samples before thermostability assays and remained in the analyzed samples during these assays.
This apparent difference was most likely due to the partial reversal of the stabilizing effects in the first
experimental group due to the decrease in the concentration of glycerol and TMAO occurring during the
purification of collagen II.
The concept of improving the structure of misfolded mutant proteins by employing chemical
chaperones to reduce the harmful effects that such mutants have on cells and tissues has been proposed
and tested with a number of proteins associated with various diseases [20; 21; 22; 23; 24]. Specific
examples of such an approach include employing TMAO to reduce the effects of mutant keratins that
cause various skin disorders and to restore the activity of mutant branched-chain α-ketoacid
dehydrogenase associated with maple syrup urine disease [25; 26]. Moreover, chemical chaperones were
shown to be effective in stabilizing the structure and accelerating the secretion of mutant proteins
involved in cystic fibrosis and Huntington’s disease, as well as liver injury and emphysema caused by an
α1-antytrypsin deficiency [27; 28; 29]. Although most studies on chemical chaperones as therapeutic
agents were done in cell culture conditions, reduction of ER stress and restoration of glucose homeostasis
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by administration of 4-phenylbutyric acid, yet another compound with chaperone-like activities, in a
mouse model of type 2 diabetes was also demonstrated, thereby indicating a potential utility of chemical
chaperones in vivo [30].
The studies presented here provide experimental evidence that the aberrant structure of collagen
mutants could be considered a target for approaches aimed at reducing the harmful effects imposed by
these mutants. Preliminary tests presented here focused on the thermolabile R789C and R992C collagen
II mutants that are associated with apoptosis and whose structural alterations are readily detectable [6; 7;
8; 31]. The structural and biological effects of these mutations, however, do not represent the full
spectrum of potential effects that different mutations may impose. For instance, in cells expressing the
thermostable R75C, R519C, and G853E collagen II mutants which are also associated with skeletal
diseases, an increase in apoptosis was not readily apparent [7]. Thus, the question remains whether
targeting the structure of collagens should be considered only for the thermolabile mutants or also for the
thermostable mutants whose ER stress-related effects may be long-term and accumulative.
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Table 1

Thermostabilities of the R789C and R992C mutant in the presence of glycerol and TMAO.

a

Chaperones added
to purified collagen isolated
from non-treated cells

Chaperones added
during cell culture

Collage
n II
variant

a

C

a

Tm75
[°C]
0.5M
Glycerol

0.1M
TMAO

C

a

Tm50
[°C]
0.5 M
Glycerol

0.1M
TMAO

C

Tm25
[°C]
0.5M
Glycerol

0.1M
TMAO

WT

40.4

40.6

40.5

41.3

41.5

41.3

42.2

42.3

42.2

R789C

37.7

37.8

37.9

38.6

38.6

38.7

39.6

39.5

39.6

R992C

38.7

39.4

39.1

39.3

39.8

39.6

40.1

40.1

40.3

WT

40.4

41.0

41.5

41.5

43.0

43.4

42.7

44.9

45.2

R789C

38.6

39.0

39.4

39.1

39.7

40.1

39.6

40.6

40.9

R992C

38.5

39.2

38.7

39.3

40.0

39.7

40.2

40.7

40.6

Tm75, Tm50, and Tm25 indicate the temperatures at which the triple helical structure of analyzed collagens

was preserved in 75%, 50%, and 25% of maximum, respectively; C indicates control samples not treated
with chemical chaperones.
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Figure Legends

Figure 1 - Relative amounts of Pro-GFP variants (A) and cPARP (B) in cells cultured in the presence of
0.5 M glycerol or 0.1 M TMAO. The relative amounts of Pro-GFP and cPARP in specific groups of cells
treated with glycerol or TMAO are compared corresponding control groups cultured in the absence of
these compounds (controls expressed as 100%). Each point represents the mean value from multiple
independent assays ± standard error of the mean (SEM). Symbols: WT, samples that include wild type
Pro-GFP; R789C and R992C, Pro-GFP mutants; ns, not statistically significant; P values for statistically
significant differences between means calculated for analyzed group and non-treated controls are also
presented (expressed as 100%).

Figure 2 – A, Assays of the thermostabilities of the WT, R789C, and R992C collagen II variants isolated
from HT-1080 cells cultured in the presence of 0.5 M glycerol or 0.1 M TMAO. B, Similar assays of the
thermostability of the WT, R789C, and R992C collagen II variants isolated from HT-1080 cells cultured
in chaperone-free media. Proteins were isolated from the media then incubated with 0.5 M glycerol or 0.1
M TMAO.
Following preincubation at increasing temperatures, collagen II samples were subjected to brief
protease digestion. The digested samples were electrophoresed in 7.5% polyacrylamide gels in reducing
conditions and then α1(II) chains were visualized by Western blot (Supplementary Figure S3).
Subsequently, the relative pixel intensities of bands corresponding to α1(II) chains were measured by
densitometry. Graphic representations of changes in the relative amount of triple-helical collagen II in
response to increasing temperature are demonstrated (see Table 1). Symbols: WT, wild type collagen II;
R789C and R992C, collagen II mutant harboring specific substitution; solid circles (●)and solid line, nontreated control; open circles (○) and dashed line, group treated with 0.5 M glycerol; triangles (▲) and
dotted lines, a group treated with 0.1 M TMAO.
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Figure 3 - Intracellular pool of Pro-GFP variants in cells cultured in the presence of glycerol or TMAO
with or without addition of 2,2' dipyridyl. A, Site-by-site comparison of Pro-GFP variants from cells
grown in the presence (+) or the absence (-) of 2,2' dipyridyl but in the absence of glycerol and TMAO. B,
Intracellular pool of the Pro-GFP variants in cells grown in the presence of glycerol or TMAO but
without 2,2' dipyridyl. C, Intracellular pool of the Pro-GFP variants in cells grown in the presence of 2,2'
dipyridyl and glycerol or TMAO. Symbols: WT, samples that include wild type Pro-GFP; R789C and
R992C, Pro-GFP mutants. Symbols: C, controls grown in the absence of glycerol (G) or TMAO (T).

Figure 4. Graphic representation of intracellular accumulation of Pro-GFP variants in cells cultured in the
presence of glycerol or TMAO with or without addition of 2,2' dipyridyl. The relative amounts of ProGFP in specific groups of cells treated with glycerol or TMAO are compared to control groups cultured in
the absence of these compounds (controls expressed as 100%). Each point represents the mean value from
multiple independent assays ± standard error of the mean (SEM).
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